|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Net (accretion) amortization of premiums and discounts from acquisition | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Deferred income tax expense (benefit) | |||||
| Net decrease (increase) in trading securities and other earning assets | |||||
| (Gains) losses on investment securities, net | |||||
| Losses (gains) on sales of assets | |||||
| Amortization of securities premiums, net of discount accretion | |||||
| Originations of loans held for sale | |||||
| Gains on sales of loans held for sale, net | |||||
| Proceeds from sales of loans held for sale | |||||
| Equity-based compensation | |||||
| Changes in: | |||||
| Accrued income | |||||
| Accrued expenses and taxes | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Securities held to maturity: | |||||
| Maturities, calls and principal repayments | |||||
| Purchases | |||||
| Securities available for sale: | |||||
| Sales | |||||
| Maturities, calls and principal repayments | |||||
| Purchases | |||||
| Equity securities with readily determinable fair values: | |||||
| Sales | |||||
| Purchases | |||||
| Equity securities without readily determinable fair values: | |||||
| Sales | |||||
| Maturities, calls and principal repayments | |||||
| Purchases | |||||
| Payment of tax equity investment commitments | |||||
| Net increase in loans | |||||
| Net (increase) decrease in fed funds sold and resell agreements | |||||
| Net cash activity from acquisitions and divestitures | |||||
| Net decrease (increase) in interest-bearing balances due from other financial institutions | |||||
| Net purchases of bank premises and equipment | |||||
| Proceeds from sales of bank premises and equipment | |||||
| Purchases of bank-owned and company-owned life insurance | |||||
| Proceeds from bank-owned and company-owned life insurance death benefit | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net increase in demand and savings deposits | |||||
| Net increase (decrease) increase in time deposits | |||||
| Net increase (decrease) in fed funds purchased and repurchase agreements | |||||
| Proceeds from short-term debt | |||||
| Repayment of short-term debt | |||||
| Repayment from long-term debt | |||||
| Cash dividends paid | |||||
| Payment of common stock issuance costs | |||||
| Proceeds from exercise of stock options and sales of treasury shares | |||||
| Purchases of treasury stock | |||||
| Common stock issuance | |||||
| Preferred stock issuance | |||||
| Preferred stock redemption | |||||
| Net cash provided by financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures: | |||||
| Income tax payments | |||||
| Total interest payments | |||||
| Noncash disclosures: | |||||
| Acquisition of tax equity investments | |||||
| Commitment to fund tax equity investments | |||||
| Transfer of loans to other real estate owned | |||||
| Transfer of loans to other repossessed assets | |||||
| Issuance of stock as consideration for acquisition | |||||
| Common Stock | |||||
| Preferred Stock | |||||
| Stock based compensation as consideration for acquisition | |||||
Loading...